George Clinical Welcomes Tony Proctor as Chief Financial Officer

December 02, 2024 11:15 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

SINGAPORE, Dec. 2, 2024 /PRNewswire/ -- George Clinical, a leading global clinical research organisation, is pleased to announce the appointment of Tony Proctor, C.P.A., as Chief Financial Officer (CFO). With over 25 years of financial leadership experience, Tony brings a wealth of expertise in driving operational excellence, strategic planning, and transformational growth.

Tony Proctor, George Clinical, Chief Financial Officer
Tony Proctor, George Clinical, Chief Financial Officer

"I am honored to join George Clinical and contribute to its mission of improving health outcomes through innovative clinical research," said Tony Proctor. "I look forward to partnering with the talented team to enhance financial operations and support the company's global vision."

Tony has held CFO and executive leadership roles at Lexitas, Parexel, and Syneos Health. He was a key architect of organic revenue acceleration initiatives at these organisations, implementing best-in-class financial disciplines, major organisational and systems upgrades, and transformative M&A processes. His leadership has consistently delivered measurable results, including driving strategic growth initiatives and optimising financial operations on a global scale.

"We are thrilled to welcome Tony to George Clinical at this exciting stage of our growth," said Mary Gunn, CEO of George Clinical. "His extensive expertise in financial strategy and operational leadership will be instrumental in advancing our business and delivering exceptional value to customers across the globe."

Tony holds an M.B.A. in Finance from Campbell University, a B.S. in Accounting, and a B.A. in Business/Finance from North Carolina State University. He is also a Certified Public Accountant (CPA) licensed in North Carolina.

About George Clinical
George Clinical is a leading global clinical research organisation headquartered in Singapore. Driven by scientific excellence and operational expertise, the company provides comprehensive clinical trial services to clients globally, offering solutions across all trial phases. For more information about George Clinical, visit www.georgeclinical.com.

Contact: Donna McDonnell, T +1 901 229 5345, [email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.